Welcome to LookChem.com Sign In|Join Free

CAS

  • or

10565-15-8

Post Buying Request

10565-15-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

10565-15-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 10565-15-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,5,6 and 5 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 10565-15:
(7*1)+(6*0)+(5*5)+(4*6)+(3*5)+(2*1)+(1*5)=78
78 % 10 = 8
So 10565-15-8 is a valid CAS Registry Number.

10565-15-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name diethyl 2-(4-methoxy-2-nitrophenyl)propanedioate

1.2 Other means of identification

Product number -
Other names diethyl 4-methoxy-2-nitrophenylmalonate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:10565-15-8 SDS

10565-15-8Relevant articles and documents

LRRK2 INHIBITORS

-

Page/Page column 130, (2013/02/28)

Provided herein are compounds that inhibit or partially inhibit the activity of leucine rich repeat kinases. Also provided herein are methods of treatment of CNS disorders comprising administration of inhibitors of leucine rich repeat kinases.

QUINOXALINE COMPOUNDS AND USE THEREOF

-

Page/Page column 72, (2008/12/08)

The present invention is related to quinoxaline compounds of Formula (I) in particular for the treatment of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.

A general oxindole synthesis

Quallich,Morrissey

, p. 51 - 53 (2007/10/02)

A general synthesis of indol-2(3H)-ones (oxindoles), was developed based on the addition of dimethyl malonate to commercially available halonitrobenzenes. The advantage of this route over many other oxindole syntheses was the regiochemical control of the substitution pattern on the aromatic ring.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 10565-15-8